University of Padua-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2021

  1. EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers

    Gut, Vol. 70, Núm. 9, pp. 1632-1641

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2018

  1. Longitudinal liquid biopsy and mathematical modeling of clonal evolution forecast time to treatment failure in the prospect-c phase ii colorectal cancer clinical trial

    Cancer Discovery, Vol. 8, Núm. 10, pp. 1270-1285

  2. MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma

    Gastroenterology, Vol. 154, Núm. 4, pp. 1066-1079.e5

  3. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers

    Science, Vol. 359, Núm. 6378, pp. 920-926

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2012

  1. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2008

  1. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

    Autophagy, Vol. 4, Núm. 2, pp. 151-175